Institute for Cancer Research

 

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded. Read more

Harald Stenmark<br>Inst. Head
Harald Stenmark
Inst. Head

Scientific production - Institute for Cancer Research

 PublicationsDoctoral theses
2017so far 
 2016235 15
201522121
201417425

Annual report 2015 (pdf format)

 

Latest news

Collaboration to identify novel biomarkers that can predict whether a patient will respond positively to pembrolizumab

 

The Norwegian bioinformatics company OncoImmunity and the Norwegian Cancer Genomics Consortium (NCGC) at Oslo University Hospital announce September 20th that they have entered into a collaboration with the American "Sarcoma Alliance for Research through Collaboration" (SARCtrials.org), to search for active neoantigens and related immune biomarker signatures of response in an American clinical trial on sarcoma patients treated with the PD1 immune checkpoint inhibitor pembrolizumab.

 
 

Sept 29th - Information day about EMBL, EMBO and HSPF:

Scientific opportunities in Europe

 

This event is open to all, and is designed to help inform Norwegian scientists about the training opportunities, services and infrastructure available at the EMBL (European Molecular Biology Laboratory). The meeting is sponsored by the EMBL Alumni Association, and has received funding from UiO: Life Science and the Research Council of Norway.  
Date & Time: 9am-6pm, Friday 29 September 2017
Location: University Library Auditorium 1, Georg Sverdrup Hus, Blindern, University of Oslo.

 
 

Jahre lecture Thursday September 14th

 
Inst. head H. Stenmark and Christer Betsholtz
Inst. head H. Stenmark and Christer Betsholtz

On Thursday September 14th The Institute for Cancer Research had the honour of hosting this year´s Jahre Prize winners for their lectures.
The lectures were by three of the leading scientists in the Nordic countries. The main prize winner (Christer Betsholtz) and one of the junior prize winners (Simon Bekker-Jensen) have their background in cancer research.

 
 

Scandic Holmenkollen Park, December 4-6, 2017:

The Norwegian Cancer symposium 2017 on Precision Medicine

 

We would like to extend an invitation to The Norwegian Cancer symposium 2017 on Precision Medicine
It will take place at Scandic Holmenkollen Park, December 4-6, 2017 in Oslo, Norway.

The meeting gathers leading national and international speakers in the field of precision medicine, and topics include the following:

  • Computational Cancer Genomics
  • Tumor Immunology and the microenvironment
  • Single cell analysis for disease trajectories and Liquid Biopsies
  • Monitoring cancer genetics in body fluids
  • Translational and clinical genomics
 
 

Anne-Lise Børresen-Dale appointed Commander of the Royal Norwegian St. Olavs Order

 

His Majesty The King has appointed Professor Emerita Anne-Lise Børresen-Dale as Commander of the Royal Norwegian St. Olavs Order for her outstanding efforts in medical research.
The decoration was be presented at an event in the Research Building at Radium Hospital in Oslo August 28.

 
 

ERC Starting Grant 2017 to Kyrre Eeg Emblem

 

The European Research Council (ERC) has awarded a Starting Grant 2017 to Kyrre Eeg Emblem from Department of Diagnostic Physics at the Divsion of Radiology & Nuclear Medicine. This is the seventh ERC Starting Grant awarded to Norway in the main panel Life Sciences (LS), and the first time Oslo University Hospital is the host institution.